Almeida Isabel F, Fernandes Eduarda, Lima José L F C, Valentão Patrícia, Andrade Paula B, Seabra Rosa M, Costa P C, Bahia M F
Departamento de Tecnologia Farmacêutica, Faculdade de Farmácia da Universidade do Porto, Porto, Portugal.
J Med Food. 2009 Feb;12(1):175-83. doi: 10.1089/jmf.2008.0046.
Eucalyptus globulus Labill. (Family Myrtaceae) is a plant of Australian origin, with a reported therapeutic use in airway inflammatory diseases. Considering that reactive oxygen species (ROS) and reactive nitrogen species (RNS) have been implicated in the pathogenesis of airway inflammatory diseases such as asthma and chronic obstructive pulmonary disease, an effective scavenging activity against these reactive species may contribute for the therapeutic effect of this plant. In the present study, a water extract of E. globulus leaves was evaluated for its putative in vitro scavenging effects on ROS (HO(), O(2)(-), ROO(), and H(2)O(2)) and RNS (()NO and ONOO(-)) and on 2,2-diphenyl-1-picrylhydrazyl radical (DPPH). Qualitative and quantitative analyses of the extract's phenolic composition were also performed. The Eucalyptus leaf water extract presented a remarkable capacity to scavenge all the reactive species tested, with all the 50% inhibitory concentrations being found at the mug/mL level. Phytochemical analysis showed the presence of polyphenols such as flavonoids (rutin and quercitrin) and phenolic acids (chlorogenic acid and ellagic acid), which may be partially responsible for the observed antioxidant activity. These observations provide further support, beyond the well-known antibacterial and antiviral activities of the Eucalyptus plant, for its reported use in traditional medicine such as in the treatment of airway inflammatory diseases, considering the important role of ROS and RNS in the inflammatory process, although further studies are needed to prove the bioavailability of the antioxidants/antibacterial compounds of the extract as well as the ability of the active compounds to reach specific tissues and to act in them.
蓝桉(桃金娘科)是一种原产于澳大利亚的植物,据报道可用于治疗气道炎症性疾病。鉴于活性氧(ROS)和活性氮(RNS)与哮喘和慢性阻塞性肺疾病等气道炎症性疾病的发病机制有关,对这些活性物质的有效清除活性可能有助于该植物的治疗效果。在本研究中,评估了蓝桉叶水提取物对ROS(羟基自由基(HO())、超氧阴离子(O₂(-))、过氧自由基(ROO())和过氧化氢(H₂O₂))、RNS(一氧化氮(()NO)和过氧亚硝酸根(ONOO(-)))以及2,2-二苯基-1-苦基肼自由基(DPPH)的体外清除作用。还对提取物的酚类成分进行了定性和定量分析。蓝桉叶水提取物对所有测试的活性物质均具有显著的清除能力,所有50%抑制浓度均在微克/毫升水平。植物化学分析表明存在多酚类物质,如黄酮类化合物(芦丁和槲皮苷)和酚酸(绿原酸和鞣花酸),这可能是观察到的抗氧化活性的部分原因。考虑到ROS和RNS在炎症过程中的重要作用,这些观察结果进一步支持了蓝桉在传统医学中的应用,如治疗气道炎症性疾病,尽管还需要进一步研究来证明提取物中抗氧化剂/抗菌化合物的生物利用度以及活性化合物到达特定组织并在其中发挥作用的能力,而蓝桉植物的抗菌和抗病毒活性是众所周知的。